S
Suzan Can
Researcher at Heidelberg University
Publications - 18
Citations - 1209
Suzan Can is an academic researcher from Heidelberg University. The author has contributed to research in topics: Thioredoxin reductase & Cancer cell. The author has an hindex of 13, co-authored 17 publications receiving 1066 citations.
Papers
More filters
Journal ArticleDOI
Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties
Riccardo Rubbiani,Igor Kitanovic,Hamed Alborzinia,Suzan Can,Ana Kitanovic,Liliane A. Onambele,Maria Stefanopoulou,Yvonne Geldmacher,William S. Sheldrick,Gerhard Wolber,Aram Prokop,Stefan Wölfl,Ingo Ott +12 more
TL;DR: Investigation of gold(I) complexes with benzimidazole derived N-heterocyclic carbene (NHC) ligands represent a promising class of gold coordination compounds with a good stability against the thiol glutathione.
Journal ArticleDOI
Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Riccardo Rubbiani,Suzan Can,Igor Kitanovic,Hamed Alborzinia,Maria Stefanopoulou,Malte Kokoschka,Susann Mönchgesang,William S. Sheldrick,Stefan Wölfl,Ingo Ott +9 more
TL;DR: Remarkable antiproliferative effects, a strong induction of apoptosis, and enhancement of reactive oxygen species (ROS) formation as well as other effects on tumor cell metabolism confirmed the promising potential of the complexes as novel anticancer chemotherapeutics.
Journal ArticleDOI
On the biological properties of alkynyl phosphine gold(I) complexes.
Andreas Meyer,Christoph P. Bagowski,Malte Kokoschka,Maria Stefanopoulou,Hamed Alborzinia,Suzan Can,Danielle H. Vlecken,William S. Sheldrick,Stefan Wölfl,Ingo Ott +9 more
TL;DR: A pilot study aimed at establishing the biological profile of alkynyl phosphine gold(I) complexes shows that the critical target enzyme thioredoxin reductase can be efficiently and selectively inhibited and that cysteine and selenocysteine residues are presumably the sites of molecular interaction with the enzyme.
Journal ArticleDOI
A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells
Xinlai Cheng,Palvo Holenya,Suzan Can,Hamed Alborzinia,Riccardo Rubbiani,Ingo Ott,Stefan Wölfl +6 more
TL;DR: The data demonstrate that MC3 efficiently suppressed cell growth, and induced cell cycle arrest and apoptosis in pancreatic cancer cells, in particular in the gemcitabine-resistant cancer cells Panc1 and ASPC1.
Journal ArticleDOI
A spontaneous gold(I)-azide alkyne cycloaddition reaction yields gold-peptide bioconjugates which overcome cisplatin resistance in a p53-mutant cancer cell line
S. David Köster,Hamed Alborzinia,Suzan Can,Igor Kitanovic,Stefan Wölfl,Riccardo Rubbiani,Ingo Ott,Phillip Riesterer,Aram Prokop,Klaus Merz,Nils Metzler-Nolte +10 more
TL;DR: Intriguingly, cisplatin-resistance in p53-mutant MDA-MB231 breast cancer cells could be overcome by the Au-peptide conjugates presented here, as indicated by flow cytometry, low mitochondrial membrane potential (MMP) and DNA fragmentation.